Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Net sales $ 4,258 $ 10,997 $ 373,948 $ 741,910
Cost of sales 1,423,904 1,476,822 3,751,674 4,847,097
Gross loss (1,419,646) (1,465,825) (3,377,726) (4,105,187)
Operating expenses        
Selling, general and administrative 2,551,406 3,363,103 6,638,350 8,766,452
Research and development 1,640,454 1,449,497 4,219,456 5,681,840
Total operating expenses 4,191,860 4,812,600 10,857,806 14,448,292
Loss from operations (5,611,506) (6,278,425) (14,235,532) (18,553,479)
Interest expense, net 5,882,081 (792,872) 23,582,427 259,177
Net loss $ (11,493,587) $ (5,485,553) $ (37,817,959) $ (18,812,656)
Net loss attributable to common stockholders, basic and diluted (in usd per share) $ (0.17) $ (0.12) $ (0.60) $ (0.42)
Weighted average number of shares outstanding, basic and diluted (in shares) 66,176,921 46,192,471 63,566,295 46,192,471